Evaluation of palpitations

Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jan 2;149(1):e1-e156.Full text  Abstract

Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016 Apr 5;133(14):e506-74.Full text  Abstract

Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018 Sep 25;138(13):e272-391.Full text  Abstract

National Institute for Health and Care Excellence. Atrial fibrillation: diagnosis and management. Jun 2021 [internet publication].Full text

1. Zimetbaum P, Josephson ME. Evaluation of patients with palpitations. N Engl J Med. 1998 May 7;338(19):1369-73 Abstract

2. Mellor GJ, Behr ER. Cardiac channelopathies: diagnosis and contemporary management. Heart. 2021 Jun 11;107(13):1092-9.

3. Wilken J. Evidence-based recommendations for the evaluation of palpitations in the primary care setting. Med Clin North Am. 2016 Sep;100(5):981-9. Abstract

4. Mayou R, Bryant B, Forfar C, et al. Non-cardiac chest pain and benign palpitations in the cardiac clinic. Br Heart J. 1994 Dec;72(6):548-53.Full text  Abstract

5. Jonsbu E, Dammen T, Morken G, et al. Patients with noncardiac chest pain and benign palpitations referred for cardiac outpatient investigation: a 6-month follow-up. Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):406-12. Abstract

6. Raviele A, Giada F, Bergfeldt L, et al. Management of patients with palpitations: a position paper from the European Heart Rhythm Association. Europace. 2011 Jul;13(7):920-34.Full text  Abstract

7. Barsky AJ, Cleary PD, Coeytaux RR, et al. Psychiatric disorders in medical outpatients complaining of palpitations. J Gen Intern Med. 1994 Jun;9(6):306-13. Abstract

8. Gillespie HS, Lin CC, Prutkin JM. Arrhythmias in structural heart disease. Curr Cardiol Rep. 2014 Aug;16(8):510. Abstract

9. Gale CP, Camm AJ. Assessment of palpitations. BMJ. 2016 Jan 6;352:h5649.

10. Barsky AJ, Cleary PD, Sarnie MK, et al. Panic disorder, palpitations, and the awareness of cardiac activity. J Nerv Ment Dis. 1994 Feb;182(2):63-71. Abstract

11. Barsky AJ, Cleary PD, Coeytaux RR, et al. The clinical course of palpitations in medical outpatients. Arch Intern Med. 1995 Sep 11;155(16):1782-8. Abstract

12. Weber BE, Kapoor WN. Evaluation and outcomes of patients with palpitations. Am J Med. 1996 Feb;100(2):138-48. Abstract

13. Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jan 2;149(1):e1-e156.Full text  Abstract

14. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020 Feb 1;41(5):655-720.Full text

15. Riley AB, Manning WJ. Atrial fibrillation: an epidemic in the elderly. Expert Rev Cardiovasc Ther. 2011 Aug;9(8):1081-90. Abstract

16. Samim D, Choffat D, Vollenweider P, et al. Prevalence of atrial fibrillation : the Swiss population-based CoLaus|PsyCoLaus study. Herz. 2023 Feb;48(1):48-54.Full text  Abstract

17. Go AS. The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg. Am J Geriatr Cardiol. 2005 Mar-Apr;14(2):56-61. Abstract

18. Marott JL, Skielboe AK, Dixen U, et al. Increasing population height and risk of incident atrial fibrillation: the Copenhagen City Heart Study. Eur Heart J. 2018 Dec 1;39(45):4012-9.Full text  Abstract

19. Crump C, Sundquist J, Winkleby MA, et al. Height, weight, and aerobic fitness level in relation to the risk of atrial fibrillation. Am J Epidemiol. 2018 Mar 1;187(3):417-26.Full text  Abstract

20. Turagam MK, Velagapudi P, Kocheril AG. Atrial fibrillation in athletes. Am J Cardiol. 2012 Jan 15;109(2):296-302. Abstract

21. Parisi EJ, Chung EH. Palpitations in athletes: diagnosis, workup and treatment. Heart. 2023 Aug 10 [Epub ahead of print]. Abstract

22. Goyal R, Zivin A, Souza J, et al. Comparison of the ages of tachycardia onset in patients with atrioventricular nodal reentrant tachycardia and accessory pathway-mediated tachycardia. Am Heart J. 1996 Oct;132(4):765-7. Abstract

23. Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016 Apr 5;133(14):e506-74.Full text  Abstract

24. Lu CW, Wu MH, Chen HC, et al. Epidemiological profile of Wolff-Parkinson-White syndrome in a general population younger than 50 years of age in an era of radiofrequency catheter ablation. Int J Cardiol. 2014 Jul 1;174(3):530-4. Abstract

25. Wolfe RR, Driscoll DJ, Gersony WM, et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect: results of 24-hour ECG monitoring. Circulation. 1993 Feb;87(2 Suppl):I89-101. Abstract

26. Pedersen OD, Bagger H, Køber L, et al. Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction. Int J Cardiol. 2005 Apr 8;100(1):65-71. Abstract

27. Diamant MJ, Andrade JG, Virani SA, et al. Heart failure and atrial flutter: a systematic review of current knowledge and practices. ESC Heart Fail. 2021 Dec;8(6):4484-96.Full text  Abstract

28. Ebert M, Richter S, Dinov B, et al. Evaluation and management of ventricular tachycardia in patients with dilated cardiomyopathy. Heart Rhythm. 2019 Apr;16(4):624-31. Abstract

29. Lukas Laws J, Lancaster MC, Ben Shoemaker M, et al. Arrhythmias as presentation of genetic cardiomyopathy. Circ Res. 2022 May 27;130(11):1698-722.Full text  Abstract

30. Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2020 Dec 22;76(25):3022-55.Full text  Abstract

31. Sen-Chowdhry S, Lowe MD, Sporton SC, et al. Arrhythmogenic right ventricular cardiomyopathy: Clinical presentation, diagnosis, and management. Am J Med. 2004 Nov 1;117(9):685-95. Abstract

32. Haugaa KH, Haland TF, Leren IS, et al. Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis. Europace. 2016 Jul;18(7):965-72.Full text  Abstract

33. Josephson ME, Wellens HJ. Differential diagnosis of supraventricular tachycardia. Cardiol Clin. 1990 Aug;8(3):411-42. Abstract

34. La Vecchia L, Ometto R, Centofante P, et al. Arrhythmic profile, ventricular function, and histomorphometric findings in patients with idiopathic ventricular tachycardia and mitral valve prolapse: clinical and prognostic evaluation. Clin Cardiol. 1998 Oct;21(10):731-5. Abstract

35. Hodzic E. Assessment of rhythm disorders in classical and nonclassical mitral valve prolapse. Med Arch. 2018 Feb;72(1):9-12.Full text  Abstract

36. Kubala M, Essayagh B, Michelena HI, et al. Arrhythmic mitral valve prolapse in 2023: evidence-based update. Front Cardiovasc Med. 2023 Apr 18:10:1130174.Full text  Abstract

37. Possner M, Gensini FJ, Mauchley DC, et al. Ebstein's anomaly of the tricuspid valve: an overview of pathology and management. Curr Cardiol Rep. 2020 Oct 9;22(12):157. Abstract

38. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000 Sep 16;356(9234):975-81. Abstract

39. Moe TG, Abrich VA, Rhee EK. Atrial fibrillation in patients with congenital heart disease. J Atr Fibrillation. 2017 Jun 30;10(1):1612.Full text  Abstract

40. Imazio M, Lazaros G, Picardi E, et al. Incidence and prognostic significance of new onset atrial fibrillation/flutter in acute pericarditis. Heart. 2015 Sep;101(18):1463-7. Abstract

41. Hassanabad AF, Deniset JF, Fedak PWM. Pericardial inflammatory mediators that can drive postoperative atrial fibrillation in cardiac surgery patients. Can J Cardiol. 2023 Aug;39(8):1090-102. Abstract

42. Neumann HPH, Young WF Jr, Eng C. Pheochromocytoma and paraganglioma. N Engl J Med. 2019 Aug 8;381(6):552-65. Abstract

43. Csengeri D, Sprünker NA, Di Castelnuovo A, et al. Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes. Eur Heart J. 2021 Mar 21;42(12):1170-7.Full text  Abstract

44. Tisdale JE, Chung MK, Campbell KB, et al. Drug-induced arrhythmias: a scientific statement from the American Heart Association. Circulation. 2020 Oct 13;142(15):e214-33.Full text  Abstract

45. Medicines and Healthcare products Regulatory Agency. Omega-3-acid ethyl ester medicines (Omacor/Teromeg 1000mg capsules): dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors. Jan 2024 [internet publication].Full text

46. Lombardi M, Carbone S, Del Buono MG, et al. Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e69-70.Full text

47. Gencer B, Djousse L, Al-Ramady OT, et al. Effect of long-term marine ɷ-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021 Dec 21;144(25):1981-90.Full text  Abstract

48. Kim EJ, Hoffmann TJ, Nah G, et al. Coffee consumption and incident tachyarrhythmias: reported behavior, mendelian randomization, and their interactions. JAMA Intern Med. 2021 Sep 1;181(9):1185-93.Full text  Abstract

49. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018 Sep 25;138(13):e272-391.Full text  Abstract

50. Varma N, Josephson ME. Therapy of "idiopathic" ventricular tachycardia. J Cardiovasc Electrophysiol. 1997 Jan;8(1):104-16. Abstract

51. Coumel P. Clinical approach to paroxysmal atrial fibrillation. Clin Cardiol. 1990 Mar;13(3):209-12. Abstract

52. Vikman S, Lindgren K, Mäkikallio TH, et al. Heart rate turbulence after atrial premature beats before spontaneous onset of atrial fibrillation. J Am Coll Cardiol. 2005 Jan 18;45(2):278-84. Abstract

53. Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002 Jun 11;105(23):2753-9. Abstract

54. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2006 Apr 15;173(8):910-6. Abstract

55. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001 Jan 2;103(1):89-95.Full text  Abstract

56. Stimpel M, Wambach G. [Plasma levels of atrial natriuretic peptide (ANP) in patients with paroxysmal supraventricular tachycardia and concomitant polyuria (urina spastica)]. [in ger]. Z Kardiol. 1988;77 Suppl 2:124-9. Abstract

57. Oliver JR, Twidale N, Lakin C, et al. Plasma atrial natriuretic polypeptide concentrations during and after reversion of paroxysmal supraventricular tachycardias. Br Heart J. 1988 Apr;59(4):458-62. Abstract

58. Brugada P, Gursoy S, Brugada J, et al. Investigation of palpitations. Lancet. 1993 May 15;341(8855):1254-8. Abstract

59. Thavendiranathan P, Bagai A, Khoo C, et al. Does this patient with palpitations have a cardiac arrhythmia? JAMA. 2009 Nov 18;302(19):2135-43. Abstract

60. Hoefman E, Boer KR, van Weert HC, et al. Continuous event recorders did not affect anxiety or quality of life in patients with palpitations. J Clin Epidemiol. 2007 Oct;60(10):1060-6. Abstract

61. Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation. 2008 Sep 30;118(14):1497-1518.Full text  Abstract

62. National Institute for Health and Care Excellence. Atrial fibrillation: diagnosis and management. Jun 2021 [internet publication].Full text

63. Agency for Healthcare Research and Quality. Remote cardiac monitoring. December 2007 [internet publication].Full text

64. Kinlay S, Leitch JW, Neil A, et al. Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations: a controlled clinical trial. Ann Intern Med. 1996 Jan 1;124(1 Pt 1):16-20. Abstract

65. Fogel RI, Evans JJ, Prystowsky EN. Utility and cost of event recorders in the diagnosis of palpitations, presyncope, and syncope. Am J Cardiol. 1997 Jan 15;79(2):207-8. Abstract

66. Zimetbaum PJ, Kim KY, Josephson ME, et al. Diagnostic yield and optimal duration of continuous-loop event monitoring for the diagnosis of palpitations: a cost-effectiveness analysis. Ann Intern Med. 1998 Jun 1;128(11):890-5. Abstract

67. Rothman SA, Laughlin JC, Seltzer J, et al. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol. 2007 Mar;18(3):241-7. Abstract

68. Svennberg E, Tjong F, Goette A, et al. How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Europace. 2022 Jul 15;24(6):979-1005.Full text

69. Narasimha D, Hanna N, Beck H, et al. Validation of a smartphone-based event recorder for arrhythmia detection. Pacing Clin Electrophysiol. 2018 Mar 1 [Epub ahead of print]. Abstract

70. National Institute for Health and Care Excellence. Heart valve disease presenting in adults: investigation and management. Nov 2021 [internet publication].Full text